Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry

Joost M Meijer¹, Hanan Rashid¹, Styliani Vergadi¹, Emiliano Antiga², Pamela Vezzoli³, Riccardo Balestri⁴, Aikaterini Patsatsi⁵, Soner Uzun⁶, Dusan Skiljevic⁷, Hana Jedlickova⁸, Lucia Janickova⁸, Alberto Corrà², Alessandra Ponziani⁹, Claudia Günther¹⁰, Giuseppe Cianchini¹¹, Matthias Schefzyk¹², Angelo Marzano¹³, Giovanni Di Zenzo¹⁴, Iakov Shimanovich¹⁵, Janet Fairley¹⁶, Jose M Mascaró Jr¹⁷, Marzia Caproni², Roberto Maglie², Enno Schmidt¹⁸, Barbara Horváth¹

Affiliations

¹ Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
² Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
³ Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
⁴ Division of Dermatology, Outpatient Consultation for Rare Diseases, Trento, Italy.
⁵ Faculty of Medicine, Papageorgiou General Hospital, 2nd Dermatology Department, Autoimmune Skin and Bullous Diseases Unit, Aristotle University, Thessaloniki, Greece.
⁶ Faculty of Medicine, Department of Dermatology, Akdeniz University, Antalya, Turkey.
⁷ Faculty of Medicine, Department of Dermatovenereology and Clinic of Dermatovenereology, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia.
⁸ I. Department of Dermatovenereology, St. Anna Hospital, Masaryk University, Brno, Czech Republic.
⁹ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
¹⁰ Department of Dermatology, Technical University Dresden, University Hospital, Dresden, Germany.
¹¹ Department of Dermatology, Ospedale classificato Cristo Re, Rome, Italy.
¹² Department of Dermatology and Allergology, Hannover Medical School, Hannover, Germany.
¹³ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy.
¹⁴ Molecular and Cell Biology Laboratory, IDI-IRCCS, Rome, Italy.
¹⁵ Department of Dermatology, University of Lübeck, Lübeck, Germany.
¹⁶ Department of Dermatology, University of Iowa, Iowa City, Iowa, USA.
¹⁷ Department of Dermatology, Universitat de Barcelona, Hospital Clínic de Barcelona, Barcelona, Spain.
¹⁸ Department of Dermatology and Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.

PMID: 37291996
DOI: 10.1111/jdv.19242

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry

Joost M Meijer et al. J Eur Acad Dermatol Venereol. 2023 Oct.

. 2023 Oct;37(10):e1189-e1191.

doi: 10.1111/jdv.19242. Epub 2023 Jun 21.

Authors

Affiliations

¹ Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
² Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
³ Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
⁴ Division of Dermatology, Outpatient Consultation for Rare Diseases, Trento, Italy.
⁵ Faculty of Medicine, Papageorgiou General Hospital, 2nd Dermatology Department, Autoimmune Skin and Bullous Diseases Unit, Aristotle University, Thessaloniki, Greece.
⁶ Faculty of Medicine, Department of Dermatology, Akdeniz University, Antalya, Turkey.
⁷ Faculty of Medicine, Department of Dermatovenereology and Clinic of Dermatovenereology, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia.
⁸ I. Department of Dermatovenereology, St. Anna Hospital, Masaryk University, Brno, Czech Republic.
⁹ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
¹⁰ Department of Dermatology, Technical University Dresden, University Hospital, Dresden, Germany.
¹¹ Department of Dermatology, Ospedale classificato Cristo Re, Rome, Italy.
¹² Department of Dermatology and Allergology, Hannover Medical School, Hannover, Germany.
¹³ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy.
¹⁴ Molecular and Cell Biology Laboratory, IDI-IRCCS, Rome, Italy.
¹⁵ Department of Dermatology, University of Lübeck, Lübeck, Germany.
¹⁶ Department of Dermatology, University of Iowa, Iowa City, Iowa, USA.
¹⁷ Department of Dermatology, Universitat de Barcelona, Hospital Clínic de Barcelona, Barcelona, Spain.
¹⁸ Department of Dermatology and Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.

PMID: 37291996
DOI: 10.1111/jdv.19242

No abstract available

PubMed Disclaimer

References

REFERENCES

1. Carugno A, Sena P, Raponi F, Robustelli Test E, Vezzoli P. Patients with bullous skin disease in a high-epidemic COVID-19 area, Bergamo. Italy Br J Dermatol. 2020;183(3):589-91.
1. Joly P, Gillibert A, Bohelay G, Aouar K, Ingen-Housz-Oro S, Bedane C, et al. Incidence and severity of COVID-19 in patients with autoimmune blistering skin diseases: a nationwide study. J Am Acad Dermatol. 2022;86(2):494-7.
1. Kridin K, Schonmann Y, Weinstein O, Schmidt E, Ludwig RJ, Cohen AD. The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: a population-based cohort study. J Am Acad Dermatol. 2021;85(1):79-87.
1. Kasperkiewicz M. COVID-19 outbreak and autoimmune bullous diseases: a systematic review of published cases. J Am Acad Dermatol. 2021;84(2):563-8.
1. Mahmoudi H, Farid AS, Nili A, Dayani D, Tavakolpour S, Soori T, et al. Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: a retrospective cohort study. J Am Acad Dermatol. 2021;84(4):1098-100.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry

Affiliations

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry

Authors

Affiliations

References

REFERENCES

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical